Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Doxorubicin-liposomal

Kidney-limited thrombotic microangiopathy

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Glezerman I, et al. Pegylated Liposomal Doxorubicin Causes Kidney-limited Thrombotic Microangiopathy. American Journal of Kidney Diseases 83 : 549-553, No. 4, Apr 2024. Available from: URL: https://dx.doi.org/10.1053/j.ajkd.2023.08.014 [summarized from abstract] Glezerman I, et al. Pegylated Liposomal Doxorubicin Causes Kidney-limited Thrombotic Microangiopathy. American Journal of Kidney Diseases 83 : 549-553, No. 4, Apr 2024. Available from: URL: https://dx.doi.org/10.1053/j.ajkd.2023.08.014 [summarized from abstract]
Metadaten
Titel
Doxorubicin-liposomal
Kidney-limited thrombotic microangiopathy
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-55553-9

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Testosterone

Case report

Multiple drugs

Case report

Antineoplastics